Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John McCafferty

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Oncotarget|March 3, 2016
Development of a specific affinity-matured exosite inhibitor to MT1-MMP that efficiently inhibits tumor cell invasion in vitro and metastasis in vivoKenneth A Botkjaer, Hang Fai Kwok, Mikkel G Terp, et al.
Mabs|October 26, 2020
Beyond affinity: selection of antibody variants with optimal biophysical properties and reduced immunogenicity from mammalian display librariesMichael R Dyson, Edward Masters, Deividas Pazeraitis, et al.
Scientific Reports|August 23, 2017
Characterization and structural determination of a new anti-MET function-blocking antibody with binding epitope distinct from the ligand binding domainDanielle M DiCara, Dimitri Y Chirgadze, Anthony R Pope, et al.
Nature Communications|November 22, 2018
Publisher Correction: In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodiesAndreas H Laustsen, Aneesh Karatt-Vellatt, Edward W Masters, et al.
Nature Communications|October 4, 2018
In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodiesAndreas H Laustsen, Aneesh Karatt-Vellatt, Edward W Masters, et al.
Nature Communications|February 8, 2023
Discovery and optimization of a broadly-neutralizing human monoclonal antibody against long-chain α-neurotoxins from snakesLine Ledsgaard, Jack Wade, Timothy P Jenkins, et al.
Mabs|February 23, 2023
Assessing developability early in the discovery process for novel biologicsMonica L Fernández-Quintero, Anne Ljungars, Franz Waibl, et al.
Annals of the Rheumatic Diseases|December 16, 2018
Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?Susan R Aungier, Alison J Cartwright, Anja Schwenzer, et al.
Mabs|June 14, 2022
<i>In vitro</i> discovery of a human monoclonal antibody that neutralizes lethality of cobra snake venomLine Ledsgaard, Andreas H Laustsen, Urska Pus, et al.
Science Signaling|June 23, 2021
Notch-IGF1 signaling during liver regeneration drives biliary epithelial cell expansion and inhibits hepatocyte differentiationSarah E Minnis-Lyons, Sofía Ferreira-González, Niya Aleksieva, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Oncotarget|March 3, 2016
Development of a specific affinity-matured exosite inhibitor to MT1-MMP that efficiently inhibits tumor cell invasion in vitro and metastasis in vivoKenneth A Botkjaer, Hang Fai Kwok, Mikkel G Terp, et al.
Mabs|October 26, 2020
Beyond affinity: selection of antibody variants with optimal biophysical properties and reduced immunogenicity from mammalian display librariesMichael R Dyson, Edward Masters, Deividas Pazeraitis, et al.
Scientific Reports|August 23, 2017
Characterization and structural determination of a new anti-MET function-blocking antibody with binding epitope distinct from the ligand binding domainDanielle M DiCara, Dimitri Y Chirgadze, Anthony R Pope, et al.
Nature Communications|November 22, 2018
Publisher Correction: In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodiesAndreas H Laustsen, Aneesh Karatt-Vellatt, Edward W Masters, et al.
Nature Communications|October 4, 2018
In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodiesAndreas H Laustsen, Aneesh Karatt-Vellatt, Edward W Masters, et al.
Nature Communications|February 8, 2023
Discovery and optimization of a broadly-neutralizing human monoclonal antibody against long-chain α-neurotoxins from snakesLine Ledsgaard, Jack Wade, Timothy P Jenkins, et al.
Mabs|February 23, 2023
Assessing developability early in the discovery process for novel biologicsMonica L Fernández-Quintero, Anne Ljungars, Franz Waibl, et al.
Annals of the Rheumatic Diseases|December 16, 2018
Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?Susan R Aungier, Alison J Cartwright, Anja Schwenzer, et al.
Mabs|June 14, 2022
<i>In vitro</i> discovery of a human monoclonal antibody that neutralizes lethality of cobra snake venomLine Ledsgaard, Andreas H Laustsen, Urska Pus, et al.
Science Signaling|June 23, 2021
Notch-IGF1 signaling during liver regeneration drives biliary epithelial cell expansion and inhibits hepatocyte differentiationSarah E Minnis-Lyons, Sofía Ferreira-González, Niya Aleksieva, et al.
Pageof 5